The Magazine for Sleep Professionals
Thursday, March 26, 2026
Sleep apnea and insomnia are two of the most prevalent sleep disorders, often coexisting and compounding the burden on patients’ quality of life. For sleep professionals, the challenge lies in unraveling the intertwined pathology of these conditions to provide effective treatment. Given this complex interplay, it is crucial to identify […]
A pediatric sleep specialist at Seattle Children’s Hospital, Lourdes DelRosso, MD, PhD, had long noted that many parents would come to a consultation with concerns that their children “moved a lot in their sleep, were tired during the day, or had problems in school.” The parents attributed the daytime symptoms […]
Insomnia is a prevalent, impactful, and costly sleep condition. Prevalence of insomnia symptoms across Europe, Canada, and the United States range from 24.8% to 40%. Disrupted sleep is seen across development and age—from infants to older adults. Medical conditions and life changes affect sleep, such as pregnancy and menopause, and […]
Since its inception in 2008, Wake Up Narcolepsy (WUN) has donated over $1.39 million to narcolepsy research. We are a nonprofit organization committed to advancing narcolepsy awareness, education, and research. A large part of our mission involves raising and allocating funding to develop improved treatments and ultimately, find a cure. […]
In the current healthcare environment, providers are facing the realities of doing more with less due to reimbursement roadblocks, staffing shortages, and inflation, to name just a few challenges. The sleep world is feeling these pain points acutely, according to Ingvar Hjalmarsson, president of Nox Medical, who notes that the […]
With roughly 30% of the U.S. population using consumer health technologies that track sleep, mobile sleep health apps have emerged as a scalable and affordable tool with the potential to improve sleep health for the general population.1 While wearables and other hardware devices often get the spotlight, the power of […]
In recent years, the landscape of sleep diagnostics has undergone a seismic shift. Home sleep tests (HSTs) have emerged as a convenient and cost-effective alternative to traditional in-lab polysomnography (PSG), challenging the very foundation of sleep laboratories. This evolution begs the question: Is the rise ofHSTs signaling the demise of […]
For many years, sleep technologists were primarily responsible for conducting overnight polysomnography (PSG) studies, performing continuous positive airway pressure (CPAP)/bilateral positive airway pressure (BiPAP) titrations, and ensuring the accuracy of diagnostic data. Their principal goal was gathering and analyzing sleep data to help physicians diagnose sleep apnea, narcolepsy, and other […]
Treating obstructive sleep apnea (OSA) is at an exciting crossroads where therapeutic advances are coming of age in the era of precision medicine. In the past, the only option was continuous positive airway pressure (CPAP) therapy. Now, there are many effective alternatives to manage sleep apnea and even more on […]
Sleep Pharmaceutical Update Nov/Dec 2024 Eight abstracts presenting data from across the sleep portfolio of Jazz Pharmaceuticals plc were featured at the 37th annual Psych Congress, held Oct. 29–Nov. 2, 2024 in Boston. That data included topline results of the Phase 4 DUET (Develop hypersomnia Understanding by Evaluating low-sodium oxybate Treatment) trial, […]
